Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat

Cancer Research

Volumn 59, Issue 5, 1999, Pages 1080-1089

  Quan, Ning ^d   Zhang, Zhao Bin ^a   Demetrikopoulos, Melissa K ^a   Kitson, Richard P ^c   Chambers, William H ^b   Goldfarb, Ronald H ^c   Weiss, Jay M ^a,e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e Emory West Campus ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE ACTIVATION; BREAST CARCINOMA; CELL MIGRATION; FLUORESCENCE ACTIVATED CELL SORTER; IMMUNOSURVEILLANCE; LUNG ALVEOLUS MACROPHAGE; LUNG METASTASIS; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR MODEL;

ADENOCARCINOMA; ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNOLOGIC SURVEILLANCE; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM METASTASIS; RATS; RATS, INBRED F344; RATS, INBRED STRAINS; SPECIES SPECIFICITY; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 0033105314     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Barlozzari, T., Leonhardt, J., Wiltrout, R. H., Herberman, R. B., and Reynolds, C. W. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J. Immunol., 134: 2783-2789, 1985.
2. van den Brink, M. R. M., Hunt, L. E., and Hiserodt, J. C. In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J. Exp. Med., 171: 197-210, 1990.
3. Ben-Eliyahu, S., Yirmiya, R., Liebeskind, J. C., Taylor, A. N., and Gale, R. P. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav. Immun., 5: 193-205, 1991.
4. Page, G. G., Ben-Eliyahu, S., and Liesbeskind, J. C. The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation of morphine. Brain Behav. Immun., 8: 241-250, 1994.
5. Marquet, R. L., Westbroek, D. L., and Jeekel, J. Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int. J. Cancer, 33: 689-692, 1984.
6. Wexler, H. Accurate identification of experimental pulmonary metastases. J. Natl. Cancer Inst., 36: 641-645, 1966.
7. Thivierge, M., and Rola-Pleszczynski, M. Enhancement of pulmonary natural killer cell activity by platelet activating factor. Am. Rev. Respir. Dis., 144: 272-277, 1991.
8. Chambers, W. H., Vujanovic, N. L., DeLeo, A. B., Olszowy, M. W., Herberman, R. B., and Hiserodt, J. C. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med., 169: 1373-1389, 1989.
9. Woollett, G. R., Barclay, A. N., Puklavec, M., and Williams, A. F. Molecular and antigenic heterogeneity of the rat leukocyte-common antigen from thymocytes and T and B lymphocytes. Eur. J. Immunol., 15: 168-173, 1985.
10. Eggermont, A. M. M., Marquet, R. L., de Bruin, R. W. F., and Jeekel, J. Effects of the interferon-inducer ABPP on colon cancer in rats; importance of tumor load and tumor site. Cancer Immunol. Immunother., 22: 217-220, 1986.
11. Schwarz, R. E., Vujanovic, N. L., and Hiserodt, J. C. Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adhering to plastic. Cancer Res., 49: 1441-1446, 1989.
12. Yuan, D., Koh, C. Y., and Wilder, J. A. Interactions between B lymphocytes and NK cells. FASEB J., 8: 1012-1018, 1994.
13. Djeu, J. Y., Heibaugh, J. A. Holden, H. T., and Herberman, R. B. Augmentation of mouse natural killer activity by interferon and interferon inducers. J. Immunol., 122: 175-181, 1979.
14. Mengel, J., Daré, L., Daré, G. M., Delgado, M., Nomizo, A., Silva, J. S., and Campas-Neto, A. An activated murine B cell lymphoma line (A-20) produces a factor-like activity which is functionally related to human natural killer cell stimulatory factor. Eur. J. Immunol., 22: 3173-3178, 1992.
15. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., and Gately, M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tremors. J. Exp. Med., 178: 1223-1230, 1993.
16. Bennink, J. R., Anderson, R., Bacik, I., Cox, J., Day, P., Deng, Y., Lapham, C., Link, H., Rustav, G., and Yewdell, J. W. Antigen processing: where tumor-specific T-cell responses begin. J. Immunother. 14: 202-208, 1993.
17. Peoples, G. E., Goedegebuure, P. S., Andrews, J. V. R., Schoof, D. D., and Eberlein, T. J. HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer. J. Immunother., 151: 5481-5491, 1993.
18. Pernis, B., and Weber, D. A. Cell biology of antigen presentation by B-lymphocytes, Contrib. Microbiol. Immunol., 11: 27-42, 1989.
19. Guo, Y., Wu, M., Chen, H., Wang, X., Liu, G., Li, G., Ma, J., and Sy, M. Effective tumor vaccine generated by fusion of hepatoma cells with activated B-lymphocytes. Science (Washington DC), 263: 518-520, 1994.